Healthcare provider profile · identity verified

Rafic Jarrah, MD

Internal Medicine · WASHINGTON, DC · NPI 1073523759

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	775	152
Amlodipine Besylate	Amlodipine Besylate	589	129
Metformin Hcl	Metformin Hcl	302	58
Losartan Potassium	Losartan Potassium	287	55
Chlorhexidine Gluconate	Chlorhexidine Gluconate	281	31
Furosemide	Furosemide	268	55
Simvastatin	Simvastatin	257	39
Lisinopril	Lisinopril	249	44
Hydrochlorothiazide	Hydrochlorothiazide	237	42
Levothyroxine Sodium	Levothyroxine Sodium	216	34
Omeprazole	Omeprazole	215	42
Tamsulosin Hcl	Tamsulosin Hcl	191	32
Metoprolol Succinate	Metoprolol Succinate	183	36
Alendronate Sodium	Alendronate Sodium	166	29
Nifedipine Er	Nifedipine	145	32
Famotidine	Famotidine	133	18
Finasteride	Finasteride	133	14
Gabapentin	Gabapentin	127	42
Potassium Chloride	Potassium Chloride	127	17
Fluticasone Propionate	Fluticasone Propionate	121	28
Pantoprazole Sodium	Pantoprazole Sodium	119	26
Albuterol Sulfate Hfa	Albuterol Sulfate	108	40
Januvia	Sitagliptin Phosphate	105	22
Hydralazine Hcl	Hydralazine Hcl	103	24
Metoprolol Tartrate	Metoprolol Tartrate	94	17
Ibuprofen	Ibuprofen	91	33
Trulicity	Dulaglutide	77	11
Telmisartan	Telmisartan	76	15
Rosuvastatin Calcium	Rosuvastatin Calcium	72	16
Allopurinol	Allopurinol	71	16
Levetiracetam	Levetiracetam	70	11
Quetiapine Fumarate	Quetiapine Fumarate	70	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	68	15
Eliquis	Apixaban	64	suppressed
Diclofenac Sodium	Diclofenac Sodium	62	20
Montelukast Sodium	Montelukast Sodium	60	12
Triamcinolone Acetonide	Triamcinolone Acetonide	58	20
Latanoprost	Latanoprost	57	suppressed
Colchicine	Colchicine	56	11
Meloxicam	Meloxicam	56	19
Oxybutynin Chloride Er	Oxybutynin Chloride	56	suppressed
Glimepiride	Glimepiride	55	14
Myrbetriq	Mirabegron	55	suppressed
Donepezil Hcl	Donepezil Hcl	54	14
Pravastatin Sodium	Pravastatin Sodium	54	12
Doxazosin Mesylate	Doxazosin Mesylate	53	suppressed
Clopidogrel	Clopidogrel Bisulfate	51	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	48	17
Clonidine Hcl	Clonidine Hcl	47	11
Valsartan	Valsartan	44	12
Ketoconazole	Ketoconazole	42	20
Lactulose	Lactulose	42	suppressed
Oxcarbazepine	Oxcarbazepine	38	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	38	suppressed
Sertraline Hcl	Sertraline Hcl	37	11
Trazodone Hcl	Trazodone Hcl	37	11
Carbamazepine	Carbamazepine	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Ozempic	Semaglutide	36	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Glipizide	Glipizide	32	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Ammonium Lactate	Ammonium Lactate	31	11
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Naproxen	Naproxen	29	16
Linzess	Linaclotide	28	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Baclofen	Baclofen	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Haloperidol	Haloperidol	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Azithromycin	Azithromycin	21	16
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Torsemide	Torsemide	19	suppressed
Cilostazol	Cilostazol	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	11
Prevalite	Cholestyramine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Dilantin	Phenytoin Sodium Extended	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Topiramate	Topiramate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Modafinil	Modafinil	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Entacapone	Entacapone	12	suppressed
Entecavir	Entecavir	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Isoniazid	Isoniazid	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nadolol	Nadolol	12	suppressed
Niacin Er	Niacin	12	suppressed
Primidone	Primidone	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Alphagan P	Brimonidine Tartrate	11	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Vyzulta	Latanoprostene Bunod	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error